期刊文献+

肾移植受者远期心脑血管疾病危险因素分析 被引量:10

Risk Factors of Long-term Cardiovascular Diseases and Cerebrovascular Diseases in Kidney Allograft Recipients
下载PDF
导出
摘要 目的探讨肾移植受者远期心脑血管疾病(CVD)的危险因素。方法采用队列研究方法对361例肾移植受者进行长期随访,随访时间点为移植后第1、6、12、24、36、48、60个月,Kaplan-Meier乘积极限法计算CVD累积发病率,COX比例风险模型进行多因素分析CVD危险因素。结果移植后1、6、12、24、36、48、60个月新发CVD累积发病率分别为3.1%、5.4%、9.9%、13.0%、18.0%、21.1%、24.1%。多因素分析结果显示,移植受者术前有CVD和糖尿病史,术后CVD发病相对危险因素(RR)分别为6.34(95%CI3.76~14.60,P=0.002)和2.19(95%CI1.32~3.97,P=0.009);移植术后糖尿病、高血压、高血脂、移植肾功能不全和蛋白尿CVD发病RR分别为2.82(95%CI1.33~7.26,P=0.002)、1.18(95%CI1.02~1.34,P=0.04)、2.04(95%CI1.26~5.17,P=0.008)、1.81(95%CI1.08~3.21,P=0.03)和1.56(95%CI1.12~3.54,P=0.05);未见移植受者性别、年龄、肥胖和移植术前高血脂与CVD发病有关。结论移植受者术前有CVD和糖尿病病史,移植术后糖尿病、高血压、高血脂、移植肾功能不全和蛋白尿是CVD发生的独立危险因素。 Objective To identify the risk factors of cardiovascular diseases and cerebrovascular diseases (CVD) events in kidney allograft recipients. Methods We followed up 361 renal transplant recipients who had undergone renal transplantation in our center from January 2000 to December 2003 and evaluated the cumulative incidences and mortalities of CVD complications at baseline and post-transplantation 1, 3, 6, 12, 24, 36, g8, and 60 months. Kaplan-Meier plot was used to assess the incidence and Cox's proportional hazards model to determine the risk factors for cardiovascular complications. Results The cumulative incidences of CVD were 3.1% , 5.4%, 9.9%, 13.0%, 18.0%, 21.1%, and24.1% 1, 6, 12, 36, 48, and60 months after transplantation, respectively. History of diabetes mellitus (RR 2. 19, 95% CI 1.32-3.97, P = 0. 009) and CVD (RR 6.34, 95% CI 3.76-14.60, P = 0. 002 ) as well as the post-transplantation hypertension (RR 1.18, 95% CI 1.02-1.34, P=0.04) , diabetes mellitus (RR2.82, 95% CI 1.33-7.26, P=0. 002), hypedipidemia (RR 2.04, 95% CI 1.26-5.17, P = 0. 008) and abnormal creatinine ( 〉 200 μmol/L, RR1.81, 95% CI 1.08-3.21, P=0.03), and proteinuria ( 〉0.3 g/d , RR 1.56, 95% CI 1.12-3.54, P = 0.05 ) were independently correlated with the development of cardiovascular events. Conclusion History of diabetes mellitus and CVD, post-transplant hypertension, diabetes mellitus, hyperlipidemia, abnormal creatinine and proteinuria are the independent risk factors of the development of CVD events.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2009年第3期284-287,共4页 Acta Academiae Medicinae Sinicae
基金 全军十一五科技攻关项目(06G115)~~
关键词 肾移植 心血管疾病 脑血管疾病 危险因素 renal transplantation cardiovascular diseases cerebrovascular diseases risk factors
  • 相关文献

参考文献15

  • 1Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant [J]. N Engl J Med, 1999, 341(23) :1725-1730.
  • 2Rao PS, Schaubel DE, Jia X, et al. Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients [ J ]. Am J Kidney Dis, 2007, 49 (2) :294-300.
  • 3Shimmura H, Tanabe K, Tokumoto T, et al. Analysis of cause of death with a functioning graft : a single-center experience [ J]. Transplant Proc, 2004, 36 (7) :2026-2029.
  • 4Vanrenterghem YF, Claes K, Montagnino G, et al. Risk factors for cardiovascular events after successful renal transplantation [ J ]. Transplantation, 2008, 85 ( 2 ) : 209-216.
  • 5Jeloka TK, Ross H, Smith R, et al. Renal transplant outcome in high-cardiovascular risk recipients [ J]. Clin Transplant, 2007, 21 (5) :609-614.
  • 6Issa N, Krowka MJ, Griffin MD, et al. Pulmonary hyperten-sion is associated with reduced patient survival after kidney transplantation [ J ]. Transplantation, 2008, 86 ( 10 ) : 1384- 1388.
  • 7Tenderich G, Fuchs U, Zittermann A, et al. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients [J]. Clin Transplant, 2007, 21(4):536-543.
  • 8Holdaas H, Fellstrom B, Jardine AG, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial [ J ]. Lancet, 2003, 361 (9374) : 2024-2031.
  • 9Jardine AG, Holdaas H, Fellstrom B, et al. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study [J]. Am J Transplant, 2004, 4(6) :988-995.
  • 10王振,石炳毅,高江平,罗芸.免疫抑制剂对人胰岛细胞的毒性作用[J].解放军医学杂志,2007,32(1):43-45. 被引量:3

二级参考文献23

  • 1赵德明,张桦,陈宏,曾龙驿,翁建平,蔡德鸿.免疫抑制剂对人胰岛细胞活性的影响[J].解放军医学杂志,2005,30(11):995-996. 被引量:1
  • 2Meredith M, Li G, Metz SA. Inhibition of calcium-induced insulin secretion from intact HIT-T15 or INS-1 beta cells by GTP depletion. Biochem Pharmacol, 1997,53 : 1873-1882.
  • 3Ishizuka J, Gugliuzza KK, Wassmuth Z, et al. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation, 1993,56 : 1486-1490.
  • 4Gray DW, McShane P, Grant A, et al. A method for isolation of islets of Langerhans from the human pancreas. Diabetes, 1984,33 : 1055-1061.
  • 5Warnock GL, Ellis D, Rajotte RV, et al. Studies of the isolation and viability of human islets of Langerhans. Transplantation,1988,45 : 957-963.
  • 6Latif ZA, Noel J,Alejandro R. et al. A simple method of staining fresh and cultured islets. Transplantation, 1988,45 : 827-830.
  • 7Aamerican Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2005,28 : 37-42.
  • 8Lawrence MC, Bhatt HS, Watterson JM, et al. Regulation of insulin gene transcription by a Ca^2+ -responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol,2001, 15 : 1758-1767.
  • 9Young MC, Kyong S, Jongwon HA, et al. High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American diabetes association criteria. Diabetes Care,2003,26: 1123-1128.
  • 10Van Hooff,Johannes P,Christiaans MH. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant,2004,19 : 8-12.

共引文献15

同被引文献85

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部